Wilson Therapeutics

De-coppering agent for the treatment of Wilson disease.

placeStockholm, Stockholm County, Sweden calendar_todayFounded 2012 groups16 employees language wilsontherapeutics.com

Innovation

5 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace dormant. Cited 40 times.

YearFilings
20131
20141
20161
20193

Investor mix

6 investors on record; lead investors include Abingworth, MVM; 2 have since exited.

Investor typeCountShare
Venture capital350%
Private equity350%
Coming soon